Does giving zinc help reduce jaundice in newborn babies receiving light treatment

Effect of oral zinc supplementation on serum bilirubin level in term neonates undergoing phototherapy a double blind randomized placebo controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102916

Enrollment

100

Registered

2026-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

Intervention1: NIL: NIL Intervention2: Oral zinc sulphate: Oral zinc sulphate at a dose of 10mg per day in two divided doses along with standard phototherapy Control Intervention1: Sucrose: Placebo in

Eligibility

Inclusion criteria

Inclusion criteria: All healthy term neonates ( 38 to 42 weeks ) Age less then 7 days Total bilirubin in range ( 15 to 25 mg per dl ) Parental consent obtained

Exclusion criteria

Exclusion criteria: Neonates with sepis or conjugated hyperbilirubinemia or rds or cephalohematoma or birth asphyxia Pre term neonates ( less than 38 weeks ) Post term neonates ( more than 41 weeks ) Congenital anomalies Neonates already on zinc therapy

Design outcomes

Primary

Measure	Time frame
We need to observe if after giving zinc therapy to neonates will serum bilirubin level decrease gradually or notTimepoint: At day 1 day 3 and day 7	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactHinal doshi

Pacific institute of medical sciences

Vivek.parasher80@gmail.com98295 93478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026